Cullinan Oncology LLC (CGEM)
US$ 16.022.82%
Price Chart
Key Statistics
Market Cap
$ 452.64M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
490.35K
52W High
$ 19.89
52W Low
$ 6.85
Dividend Yield
0.00%
Beta
-0.08
Technicals
50-Day MA
8.1001
200-Day MA
10.1437
52 Week High
19.89
52 Week Low
6.85
About CGEM
Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.
Employees
111
Headquarters
Cambridge, MA
CEO
Mr. Nadim Ahmed
Latest News
Cullinan Therapeutics: Betting On Zipalertinib NDA Catalyst - Seeking Alpha
3 weeks ago • Google News
What does CGEM's flat EPS in 2024 indicate for investors? - AInvest
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg